Search research articles
Contact Us
Filters
Showing results (141-150 of 210) with videos related to
Page
of 21
Sort By:
European Heart Journal
|
June 15, 2014
Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure
Ewa A Jankowska, Monika Kasztura, Mateusz Sokolski, et al.
European Journal of Heart Failure
|
November 3, 2025
Urinary markers in heart failure - types, timing and thresholds. European Journal of Heart Failure expert consensus document
Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, et al.
Scientific Reports
|
May 14, 2026
Urinary potassium/urinary creatinine ratio in outpatients with heart failure: factors associated and prognostic implications
Gema Miñana, Neus Valls, Miguel Lorenzo, et al.
Journal of Cardiac Failure
|
February 13, 2025
Reprieve System for the Treatment of Patients With Acute Decompensated Heart Failure
Juan B Ivey-Miranda, Veena S Rao, Tamaz Shaburishvili, et al.
European Journal of Heart Failure
|
October 29, 2025
The chloride paradigm shift in heart failure: From neglected ion to keystone of precision diuretic therapy
Jaime Mazón-Ruiz, Eduardo Josué Banegas-Deras, Jose María Fernández-Rodríguez, et al.
European Journal of Heart Failure
|
February 21, 2025
Low blood pressure and the effect of empagliflozin in acute heart failure: An EMPULSE analysis
João Pedro Ferreira, Francisco Vasques-Nóvoa, Christiane E Angermann, et al.
European Journal of Heart Failure
|
February 20, 2021
Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
Jasper Tromp, Piotr Ponikowski, Afshin Salsali, et al.
European Journal of Heart Failure
|
April 4, 2024
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial
Jasper Tromp, Mikhail N Kosiborod, Christiane E Angermann, et al.
European Heart Journal
|
October 18, 2022
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
Jan Biegus, Adriaan A Voors, Sean P Collins, et al.
JACC. Heart Failure
|
March 7, 2026
Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE
Christiane E Angermann, Teresa Gerhardt, Jonathan P Blatchford, et al.
Page
of 21
Search research articles
Search
Showing results (141-150 of 210) with videos related to
Sort By:
Page
of 21
European Heart Journal
|
June 15, 2014
Iron deficiency defined as depleted iron stores accompanied by unmet cellular iron requirements identifies patients at the highest risk of death after an episode of acute heart failure
Ewa A Jankowska, Monika Kasztura, Mateusz Sokolski, et al.
European Journal of Heart Failure
|
November 3, 2025
Urinary markers in heart failure - types, timing and thresholds. European Journal of Heart Failure expert consensus document
Masatake Kobayashi, Biykem Bozkurt, Peder Langeland Myhre, et al.
Scientific Reports
|
May 14, 2026
Urinary potassium/urinary creatinine ratio in outpatients with heart failure: factors associated and prognostic implications
Gema Miñana, Neus Valls, Miguel Lorenzo, et al.
Journal of Cardiac Failure
|
February 13, 2025
Reprieve System for the Treatment of Patients With Acute Decompensated Heart Failure
Juan B Ivey-Miranda, Veena S Rao, Tamaz Shaburishvili, et al.
European Journal of Heart Failure
|
October 29, 2025
The chloride paradigm shift in heart failure: From neglected ion to keystone of precision diuretic therapy
Jaime Mazón-Ruiz, Eduardo Josué Banegas-Deras, Jose María Fernández-Rodríguez, et al.
European Journal of Heart Failure
|
February 21, 2025
Low blood pressure and the effect of empagliflozin in acute heart failure: An EMPULSE analysis
João Pedro Ferreira, Francisco Vasques-Nóvoa, Christiane E Angermann, et al.
European Journal of Heart Failure
|
February 20, 2021
Sodium-glucose co-transporter 2 inhibition in patients hospitalized for acute decompensated heart failure: rationale for and design of the EMPULSE trial
Jasper Tromp, Piotr Ponikowski, Afshin Salsali, et al.
European Journal of Heart Failure
|
April 4, 2024
Treatment effects of empagliflozin in hospitalized heart failure patients across the range of left ventricular ejection fraction - Results from the EMPULSE trial
Jasper Tromp, Mikhail N Kosiborod, Christiane E Angermann, et al.
European Heart Journal
|
October 18, 2022
Impact of empagliflozin on decongestion in acute heart failure: the EMPULSE trial
Jan Biegus, Adriaan A Voors, Sean P Collins, et al.
JACC. Heart Failure
|
March 7, 2026
Empagliflozin in De Novo vs Acute Decompensated Chronic Heart Failure: A Prespecified Analysis From EMPULSE
Christiane E Angermann, Teresa Gerhardt, Jonathan P Blatchford, et al.
Page
of 21